AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25947257 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone (DEX) on days 1, 2, and 3
Number of subjects: 82
Study 23047373 — intervention group
Group type: EXPERIMENTAL
Intervention: Early pregait balance training with visual biofeedback and body weight support harness system
Number of subjects: 28
Study 23047373 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 28
Study 22088980 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel 75 mg daily
Number of subjects: 333
Study 22088980 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel 225 mg daily
Number of subjects: 333
Study 22088980 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel 300 mg daily
Number of subjects: 333
Study 22088980 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel 225 or 300 mg daily
Number of subjects: 333
Study 18781341 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative chemotherapy (three cycles) of gemcitabine plus carboplatin or paclitaxel
Number of subjects: 43
Study 18781341 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative chemotherapy (three cycles) of gemcitabine plus carboplatin or cisplatin
Number of subjects: 43
Study 16046076 — intervention group
Group type: EXPERIMENTAL
Intervention: Betablocker (BB) propranolol 80 mg
Number of subjects: 30
Study 16046076 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 30
Study 12651798 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical competence
Number of subjects: 60
Study 12651798 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-centredness
Number of subjects: 60
Study 12651798 — intervention group
Group type: EXPERIMENTAL
Intervention: More clinically competent interviews
Number of subjects: 60
Study 10751736 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone 100 mg/kg/day for 1-3 weeks
Number of subjects: 118
Study 8602664 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% magnesium sulfate
Number of subjects: 42
Study 8602664 — intervention group
Group type: COMPARATOR
Intervention: saline (control)
Number of subjects: 42
Study 1286181 — intervention group
Group type: EXPERIMENTAL
Intervention: Andriol
Number of subjects: 0
Study 1286181 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study 2932742 — intervention group
Group type: EXPERIMENTAL
Intervention: Secnidazole (2 g single oral dose)
Number of subjects: 80
Study 2932742 — intervention group
Group type: COMPARATOR
Intervention: Tetracycline (750 mg per day for 5 days) plus Clioquinol (1 g per day)
Number of subjects: 80
Study 30046828 — intervention group
Group type: EXPERIMENTAL
Intervention: CER-001, 3 mg/kg, administered as 10 weekly intravenous infusions
Number of subjects: 293
Study 30046828 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 293
Study 26945658 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin 400 mg (oral)
Number of subjects: 447
Study 26945658 — intervention group
Group type: COMPARATOR
Intervention: Levofloxacin 400 mg (oral) + Amikacin 200 mg (intravenous)
Number of subjects: 447
Study 24751903 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG‐IFNa‐2a
Number of subjects: 30
Study 24751903 — intervention group
Group type: COMPARATOR
Intervention: RBV monotherapy
Number of subjects: 30
Study 24751903 — intervention group
Group type: COMPARATOR
Intervention: RBV combination therapy
Number of subjects: 30
Study 24751903 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG‐IFNa/RBV combination therapy
Number of subjects: 30
Study 22527075 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin 300 mg/day
Number of subjects: 92
Study 22527075 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study 20075643 — intervention group
Group type: EXPERIMENTAL
Intervention: Desvenlafaxine (200-400 mg/d)
Number of subjects: 575
Study 20075643 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 575
Study 18570573 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary VATS
Number of subjects: 49
Study 18570573 — intervention group
Group type: COMPARATOR
Intervention: Chest tube therapy
Number of subjects: 49
Study 16225405 — intervention group
Group type: EXPERIMENTAL
Intervention: Special care (genetic counseling after explaining the sweat test result and offering of parental DNA testing on the sweat test visit)
Number of subjects: 39
Study 16225405 — intervention group
Group type: COMPARATOR
Intervention: Standard care (sweat test result reported by phone the next day with recommendation for genetic counseling and parental carrier testing)
Number of subjects: 39
Study 11843062 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN induction/ribavirin
Number of subjects: 256
Study 11843062 — intervention group
Group type: COMPARATOR
Intervention: Standard IFN/ribavirin
Number of subjects: 256
Study 11843062 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN induction/ribavirin (genotype 2b/3a)
Number of subjects: 256
Study 11843062 — intervention group
Group type: COMPARATOR
Intervention: Standard combination therapy (genotype 2b/3a)
Number of subjects: 256
Study 12038914 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone
Number of subjects: 378
Study 12038914 — intervention group
Group type: EXPERIMENTAL
Intervention: Fax
Number of subjects: 378
Study 12038914 — intervention group
Group type: EXPERIMENTAL
Intervention: E-mail
Number of subjects: 378
Study 12038914 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 378
Study 9727760 — intervention group
Group type: EXPERIMENTAL
Intervention: Abstracts concluded that the test treatment was as effective as or better than the control treatment
Number of subjects: 178
Study 9727760 — intervention group
Group type: EXPERIMENTAL
Intervention: Abstracts concluded that the test treatment was not as effective as the control treatment
Number of subjects: 178
Study 9727760 — intervention group
Group type: EXPERIMENTAL
Intervention: Sample size of the trials
Number of subjects: 178
Study 9727760 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall publication rates
Number of subjects: 178
Study 8063650 — intervention group
Group type: EXPERIMENTAL
Intervention: Epinephrine (15 ng.kg‐1.min‐1)
Number of subjects: 10
Study 8063650 — intervention group
Group type: EXPERIMENTAL
Intervention: Norepinephrine (30 ng.kg‐1.min‐1)
Number of subjects: 10
Study 8063650 — intervention group
Group type: EXPERIMENTAL
Intervention: Epinephrine and Norepinephrine
Number of subjects: 10
Study 3150128 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged physical stress (5 days of continuous heavy exercise, caloric deficiency, and sleep deprivation)
Number of subjects: 8
Study 3150128 — intervention group
Group type: COMPARATOR
Intervention: Control experiment (performed 8 weeks later)
Number of subjects: 8
Study 28456058 — intervention group
Group type: EXPERIMENTAL
Intervention: No disclaimer label
Number of subjects: 320
Study 28456058 — intervention group
Group type: EXPERIMENTAL
Intervention: Small disclaimer label
Number of subjects: 320
Study 28456058 — intervention group
Group type: EXPERIMENTAL
Intervention: Large disclaimer label
Number of subjects: 320
Study 28456058 — intervention group
Group type: EXPERIMENTAL
Intervention: Very large disclaimer label
Number of subjects: 320
Study 28456058 — intervention group
Group type: COMPARATOR
Intervention: Product images
Number of subjects: 320
Study 25155105 — intervention group
Group type: COMPARATOR
Intervention: 200 mg on-demand udenafil
Number of subjects: 161
Study 25155105 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg once-daily udenafil
Number of subjects: 161
Study 23391421 — intervention group
Group type: EXPERIMENTAL
Intervention: G-CSF (10 μg/kg)
Number of subjects: 52
Study 23391421 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 21573977 — intervention group
Group type: EXPERIMENTAL
Intervention: Over-the-counter orlistat supply
Number of subjects: 4026
Study 18500062 — intervention group
Group type: COMPARATOR
Intervention: Mechanical debridement only (Group 1)
Number of subjects: 29
Study 18500062 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical debridement followed by monopolar radiofrequency (Group 2)
Number of subjects: 29
Study 17699350 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous C.E.R.A. 0.4 microg/kg
Number of subjects: 16
Study 17699350 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous C.E.R.A. 0.8 microg/kg
Number of subjects: 16
Study 15074443 — intervention group
Group type: EXPERIMENTAL
Intervention: Word recognition in quiet at 60 dB and 80 dB HL
Number of subjects: 48
Study 15074443 — intervention group
Group type: EXPERIMENTAL
Intervention: Word recognition in babble at 4.1 dB S/B
Number of subjects: 48
Study 15074443 — intervention group
Group type: EXPERIMENTAL
Intervention: Word recognition in babble at 9.4 dB S/B
Number of subjects: 48
Study 15074443 — intervention group
Group type: EXPERIMENTAL
Intervention: Word recognition in babble at 6 dB S/B
Number of subjects: 48
Study 15074443 — intervention group
Group type: COMPARATOR
Intervention: Listeners with hearing loss
Number of subjects: 48
Study 15074443 — intervention group
Group type: EXPERIMENTAL
Intervention: Test-retest reliability
Number of subjects: 48
Study 10757572 — intervention group
Group type: EXPERIMENTAL
Intervention: Milrinone (0.5 microg x kg(‐1) x min(‐1))
Number of subjects: 20
Study 10757572 — intervention group
Group type: COMPARATOR
Intervention: Control (continued catecholamine therapy without milrinone)
Number of subjects: 20
Study 8817282 — intervention group
Group type: EXPERIMENTAL
Intervention: Valid transient peripheral cue presented 100 ms before target occurrence (100% valid cue with 100 ms lead time)
Number of subjects: 7
Study 8817282 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninformative cues presented consistently on either left or right side
Number of subjects: 7
Study 8817282 — intervention group
Group type: COMPARATOR
Intervention: Control session with no cue
Number of subjects: 7
Study 1582303 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefotaxime 2 g every 12 h
Number of subjects: 50
Study 1582303 — intervention group
Group type: COMPARATOR
Intervention: Cefotaxime 2 g every 8 h
Number of subjects: 50
Study 31107983 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal glycaemic control (higher HbA1c and lower continuous glucose monitoring time‐in‐range)
Number of subjects: 225
Study 31107983 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous glucose monitoring time‐in‐target (5-7% increase) during the second and third trimesters
Number of subjects: 225
Study 31107983 — intervention group
Group type: EXPERIMENTAL
Intervention: Neonates with hypoglycaemia
Number of subjects: 225
Study 28653239 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted ERAS
Number of subjects: 99
Study 28653239 — intervention group
Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 99
Study 25952587 — intervention group
Group type: EXPERIMENTAL
Intervention: MSInvigor8-Plus (with email support)
Number of subjects: 39
Study 25952587 — intervention group
Group type: COMPARATOR
Intervention: MSInvigor8-Only (without email support)
Number of subjects: 39
Study 25952587 — intervention group
Group type: EXPERIMENTAL
Intervention: MSInvigor8-Plus
Number of subjects: 39
Study 25952587 — intervention group
Group type: COMPARATOR
Intervention: MSInvigor8-Only
Number of subjects: 39
Study 24458836 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-based behavioral weight loss treatment (FBT) program, 16 sessions
Number of subjects: 170
Study 22078144 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine
Number of subjects: 28
Study 22078144 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face examination
Number of subjects: 28
Study 19900797 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma Control Test (ACT) score
Number of subjects: 0
Study 19900797 — intervention group
Group type: COMPARATOR
Intervention: Doctor's assessment of asthma control
Number of subjects: 0
Study 19900797 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient self-assessment of asthma control
Number of subjects: 0
Study 19900797 — intervention group
Group type: COMPARATOR
Intervention: Disagreement with doctor's assessment
Number of subjects: 0
Study 19900797 — intervention group
Group type: COMPARATOR
Intervention: Therapeutic interventions (excluding combination products)
Number of subjects: 0
Study 17667481 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive behavior therapy
Number of subjects: 487
Study 17667481 — intervention group
Group type: EXPERIMENTAL
Intervention: MTA children
Number of subjects: 487
Study 17667481 — intervention group
Group type: EXPERIMENTAL
Intervention: Prescribed medication
Number of subjects: 487
Study 16219252 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone triage by physicians
Number of subjects: 2560
Study 12360153 — intervention group
Group type: EXPERIMENTAL
Intervention: Avasimibe at 50 mg daily
Number of subjects: 0
Study 12360153 — intervention group
Group type: EXPERIMENTAL
Intervention: Avasimibe at 250 mg daily
Number of subjects: 0
Study 12360153 — intervention group
Group type: EXPERIMENTAL
Intervention: Avasimibe at 750 mg daily
Number of subjects: 0
Study 12360153 — intervention group
Group type: COMPARATOR
Intervention: Background lipid-lowering therapy
Number of subjects: 0
Study 10427802 — intervention group
Group type: EXPERIMENTAL
Intervention: Classical acupuncture (group A)
Number of subjects: 14
Study 10427802 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture (group S)
Number of subjects: 14
Study 7538714 — intervention group
Group type: EXPERIMENTAL
Intervention: TULIP (transurethral ultrasound‐guided laser‐induced prostatectomy)
Number of subjects: 83
Study 2076239 — intervention group
Group type: EXPERIMENTAL
Intervention: Status composite material
Number of subjects: 40
Study 2076239 — intervention group
Group type: EXPERIMENTAL
Intervention: Ful-Fil composite material
Number of subjects: 40
Study 2076239 — intervention group
Group type: EXPERIMENTAL
Intervention: Laminate technique with glass ionomer base
Number of subjects: 40
Study 2076239 — intervention group
Group type: EXPERIMENTAL
Intervention: Unlaminated technique without glass ionomer base
Number of subjects: 40
Study 6794587 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg diazepam
Number of subjects: 6
Study 6794587 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg temazepam
Number of subjects: 6
Study 6794587 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg flurazepam
Number of subjects: 6
Study 6794587 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg nitrazepam
Number of subjects: 6
Study 6794587 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg desmethyl‐diazepam
Number of subjects: 6
Study 6794587 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 30573355 — intervention group
Group type: EXPERIMENTAL
Intervention: Drink rich in polyphenols from red grape pomace (RGPD) - 1.562 g gallic acid equivalents (GAE)
Number of subjects: 12
Study 30573355 — intervention group
Group type: COMPARATOR
Intervention: Control drink (CD, no polyphenols)
Number of subjects: 12
Study 28059960 — intervention group
Group type: EXPERIMENTAL
Intervention: Primed decision making (video paradigms declared the next operative maneuver)
Number of subjects: 22
Study 28059960 — intervention group
Group type: EXPERIMENTAL
Intervention: Unprimed decision making (video paradigms withheld the next operative maneuver)
Number of subjects: 22
Study 28059960 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision consistency
Number of subjects: 22
Study 28059960 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall decision making
Number of subjects: 22
Study 27776459 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant sterols-enriched soy milk (2.0 g free plant sterols daily)
Number of subjects: 18
Study 27776459 — intervention group
Group type: COMPARATOR
Intervention: Placebo soy milk (20g)
Number of subjects: 18
Study 24061500 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand-assisted colorectal resection
Number of subjects: 245
Study 24061500 — intervention group
Group type: COMPARATOR
Intervention: Open colorectal resection
Number of subjects: 245
Study 22194005 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIT)
Number of subjects: 15
Study 22194005 — intervention group
Group type: COMPARATOR
Intervention: Endurance Training (ET)
Number of subjects: 15
Study 19786306 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal saline nasal irrigation
Number of subjects: 69
Study 19786306 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal saline nasal irrigation in atopy group
Number of subjects: 69
Study 19786306 — intervention group
Group type: COMPARATOR
Intervention: Control group (no nasal irrigation)
Number of subjects: 69
Study 17245799 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly, monthly, or occasional religious participation
Number of subjects: 1610
Study 17245799 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequency of religious participation
Number of subjects: 1610
Study 17245799 — intervention group
Group type: COMPARATOR
Intervention: No religious participation
Number of subjects: 1610
Study 17245799 — intervention group
Group type: COMPARATOR
Intervention: Mental health service utilization
Number of subjects: 1610
Study 15119158 — intervention group
Group type: EXPERIMENTAL
Intervention: Qi Jie Granule
Number of subjects: 102
Study 15119158 — intervention group
Group type: COMPARATOR
Intervention: Qian Jin Pian
Number of subjects: 102
Study 11309552 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebivolol (5 mg once a day)
Number of subjects: 12
Study 11309552 — intervention group
Group type: COMPARATOR
Intervention: Atenolol (50 mg once a day)
Number of subjects: 12
Study 9684663 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisapride 20 mg
Number of subjects: 101
Study 9684663 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study 7851254 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes education and care program
Number of subjects: 137
Study 2837300 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril 5 mg twice each week
Number of subjects: 25
Study 2837300 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 31391505 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous auricular vagus nerve stimulation (taVNS)
Number of subjects: 33
Study 31391505 — intervention group
Group type: COMPARATOR
Intervention: Sham (placebo) stimulation
Number of subjects: 33
Study 28147226 — intervention group
Group type: EXPERIMENTAL
Intervention: BLI (blue laser imaging)
Number of subjects: 963
Study 28147226 — intervention group
Group type: COMPARATOR
Intervention: WLI (white-light imaging)
Number of subjects: 963
Study 26345187 — intervention group
Group type: EXPERIMENTAL
Intervention: Yearlong partly supervised mixed exercise intervention (endurance and resistance exercises, 3‐5 times per week)
Number of subjects: 256
Study 26345187 — intervention group
Group type: COMPARATOR
Intervention: Progressive muscle relaxation training (Jacobsen method) with the same frequency
Number of subjects: 256
Study 23997711 — intervention group
Group type: COMPARATOR
Intervention: CPAP
Number of subjects: 126
Study 23997711 — intervention group
Group type: EXPERIMENTAL
Intervention: MAD
Number of subjects: 126
Study 21228781 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple guidance group (n = 52)
Number of subjects: 109
Study 21228781 — intervention group
Group type: COMPARATOR
Intervention: Single guidance group (n = 57)
Number of subjects: 109
Study 19549676 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticoagulation protocol during defibrillation testing
Number of subjects: 0
Study 17717446 — intervention group
Group type: EXPERIMENTAL
Intervention: External stent inserted across the anastomosis to drain the pancreatic duct
Number of subjects: 120
Study 17717446 — intervention group
Group type: COMPARATOR
Intervention: No stent
Number of subjects: 120
Study 17717446 — intervention group
Group type: EXPERIMENTAL
Intervention: External stent inserted
Number of subjects: 120
Study 16314615 — intervention group
Group type: EXPERIMENTAL
Intervention: ABVD
Number of subjects: 807
Study 16314615 — intervention group
Group type: COMPARATOR
Intervention: MDRs
Number of subjects: 807
Study 12846491 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen (administered for at least 3 years)
Number of subjects: 0
Study 9458200 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid
Number of subjects: 307
Study 9458200 — intervention group
Group type: EXPERIMENTAL
Intervention: Folinic acid
Number of subjects: 307
Study 9458200 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 307
Study 7544228 — intervention group
Group type: EXPERIMENTAL
Intervention: Procaterol (50 micrograms)
Number of subjects: 8
Study 7544228 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 2665661 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose trimethoprim
Number of subjects: 106
Study 2665661 — intervention group
Group type: COMPARATOR
Intervention: Seven day course of co‐trimoxazole
Number of subjects: 106
Study 81636 — intervention group
Group type: EXPERIMENTAL
Intervention: Inosiplex
Number of subjects: 39
Study 81636 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 31780257 — intervention group
Group type: EXPERIMENTAL
Intervention: C-MAC video laryngoscope
Number of subjects: 218
Study 31780257 — intervention group
Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 218
Study 31702684 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular training (NMT)
Number of subjects: 88
Study 31702684 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 88
Study 28231041 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent intervention including motivational interviewing by telephone and educational materials with biblical messages, church-based group activities, and environmental cues.
Number of subjects: 75
Study 28231041 — intervention group
Group type: COMPARATOR
Intervention: Control group received the same type and frequency of intervention components related to fruit and vegetable consumption.
Number of subjects: 75
Study 25782660 — intervention group
Group type: EXPERIMENTAL
Intervention: Infant formula based on whole goats' milk (GIF)
Number of subjects: 3
Study 25782660 — intervention group
Group type: COMPARATOR
Intervention: Control cows' milk infant formula based on vegetable oils (VIF)
Number of subjects: 3
Study 25782660 — intervention group
Group type: EXPERIMENTAL
Intervention: Fully breast-fed infants
Number of subjects: 3
Study 23280432 — intervention group
Group type: EXPERIMENTAL
Intervention: SIT group (specific immunotherapy)
Number of subjects: 32